Skip to main content
New Horizon Biotech Ltd.
New Horizon Biotech Ltd.
Your life is our life

  • About New Horizon Biotech

    Founded in 2002, New Horizon Biotech began with a focused role in the medical device supply base, producing precision components such as micro-sensors and biocompatible adhesives. As global demand for diabetes care technologies expanded, NHB grew into a specialized Class II medical device manufacturer with a portfolio spanning insulin delivery, continuous glucose monitoring, and blood glucose monitoring solutions. 

    Today, the company operates through a globally connected model that links headquarters and core manufacturing in Shenzhen with commercial and regulatory coordination in Seattle, EU compliance and late-stage customization in Budapest, and logistics support in Monterrey. This structure allows NHB to stay close to major healthcare markets while maintaining the agility of a mid-sized organization.

Founded in 
​2002

Global Operating Hubs
4 Locations

Core Product Lines
3 Platforms

New Horizon Biotech combines product development, global operations, and quality-driven execution to support diabetes management technologies across regulated healthcare markets.

Product Development
​NHB develops diabetes management technologies across insulin delivery, continuous glucose monitoring, and blood glucose monitoring. The company’s portfolio is built to support practical healthcare needs while maintaining long-term product relevance across regulated markets.

Global Operations
​With headquarters and primary manufacturing in Shenzhen, strategic coordination in Seattle, EU support in Budapest, and logistics capability in Monterrey, NHB operates through a globally connected model designed for flexibility and responsiveness.

Quality & Regulatory Coordination
​NHB’s operating model is structured around internationally recognized medical device quality and regulatory frameworks, with coordination across U.S., EU, and other global market requirements. This approach helps align product, documentation, and market readiness within a single operating structure.